These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19209142)

  • 1. Acquired factor V inhibitor in a patient with gingival squamous cell cancer and tuberculosis.
    Chenthilmurugan R; Kodali S; Chenthilmurugan H; Steier W; Schwartz J; Kalavar M
    Clin Adv Hematol Oncol; 2008 Dec; 6(12):921-7. PubMed ID: 19209142
    [No Abstract]   [Full Text] [Related]  

  • 2. Late and fatal deterioration of an intracerebral hemorrhage attributable to the onset of a high titer of acquired factor V inhibitor.
    Denier C; Bouteredjiret T; Dreyfus M; Lacroix C; Adams D
    Eur Neurol; 2008; 60(4):206-7. PubMed ID: 18667829
    [No Abstract]   [Full Text] [Related]  

  • 3. [Factor V inhibitor developing in a patient with pulmonary tuberculosis (author's transl)].
    Takase T; Fujimura Y; Mikami S; Fukui H; Fukui H; Tsujii T; Hashimoto A
    Rinsho Ketsueki; 1980 Jul; 21(7):1038-46. PubMed ID: 7420740
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of cephradine-induced acquired factor V inhibitors: a case report.
    Wu MT; Pei SN
    Ann Pharmacother; 2010 Oct; 44(10):1673-6. PubMed ID: 20807866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired factor V inhibitor after haematopoietic stem cell transplantation.
    Milojkovic D; Patel R; Ford E; Arya R; Mufti G
    Thromb Haemost; 2007 Sep; 98(3):685-7. PubMed ID: 17849062
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired factor V inhibitor in a critically ill patient.
    Morris CJ; Curry N
    Anaesthesia; 2009 Sep; 64(9):1014-7. PubMed ID: 19686488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
    Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
    Borucki K; Töpfer G; Hartung KJ; Lutze G
    Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.
    Wiwanitkit V
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):485-8. PubMed ID: 17000894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pericardial effusion in a patient with acquired factor V inhibitor.
    Bulcão Macedo FY; Coterell S; Sidney D; Bellaguarda E; Franco R; Castrellon A; Byrnes J
    Ann Hematol; 2008 Apr; 87(4):339-41. PubMed ID: 18040686
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor V inhibitor: case report.
    Leus B; Devreese K; van den Bossche J; Malfait R
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):585-7. PubMed ID: 16988556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired factor V inhibitor and single exposure to autologous growth factor.
    Shah AK; Moreno-Aspitia A
    Thromb Res; 2005; 116(1):87-9. PubMed ID: 15850612
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acquired coagulation abnormality due to factor V inhibitor].
    Iino N; Maruyama H; Gejyo F
    Nihon Naika Gakkai Zasshi; 2002 Nov; 91(11):3295-7. PubMed ID: 12652782
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous resolution of acquired factor V inhibitor associated with ovarian carcinoma.
    Maughan EO; Wilson J; Wilde JT
    Int J Lab Hematol; 2007 Aug; 29(4):316-9. PubMed ID: 17617083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-factor V acquired circulating anticoagulant in rheumatoid arthritis].
    Heuline A; Siame JL; Jude B; Parquet A
    Rev Rhum Mal Osteoartic; 1990 May; 57(5):442. PubMed ID: 2374874
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acquired anti-factor V circulating anticoagulant and immunologic diseases].
    Taillan B; Ferrari E; Fuzibet JG; Vinti H; Gratecos N; Dujardin P
    Rev Rhum Mal Osteoartic; 1991 Mar; 58(3):232. PubMed ID: 2057705
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of an asymptomatic idiopathic inhibitor to coagulation factor V.
    Lucia JF; Aguilar C
    Haemophilia; 2005 Mar; 11(2):178-80. PubMed ID: 15810922
    [No Abstract]   [Full Text] [Related]  

  • 18. An inhibitor against factor V occurring postoperatively in a case of pancreatic cancer.
    Kuto M; Izuchi Y; Deguchi K; Morito T; Lee C; Wada H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):938-50. PubMed ID: 7331712
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of facial pain caused by lung cancer.
    Nestor JJ; Ngo LK
    Otolaryngol Head Neck Surg; 1994 Jul; 111(1):155-6. PubMed ID: 8028934
    [No Abstract]   [Full Text] [Related]  

  • 20. Case report: Esophageal histoplasmosis associated with disseminated tuberculosis in acquired immunodeficiency syndrome.
    Rezende RE; Brunaldi MO; Girão MS; Zucoloto S; Garcia SB; Machado AA; Módena JL
    Am J Trop Med Hyg; 2009 Mar; 80(3):347-50. PubMed ID: 19270280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.